We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Johnson & Johnson (J&J) has secured a $1 billion contract from the U.S. government to manufacture 100 million doses of its COVID-19 vaccine candidate Ad26.COV2.S. Read More
Pfizer and BioNTech have signed an agreement with Japan’s Ministry of Health to supply the country with 120 million doses of their COVID-19 vaccine. Read More
Sanofi and GlaxoSmithKline (GSK) have secured a $2.1 billion U.S. government contract to develop and produce 100 million doses of their COVID-19 vaccine candidate. Read More
Sanofi and GlaxoSmithKline have reached a deal with the British government that will secure up to 60 million doses of the drugmakers’ experimental COVID-19 vaccine for the UK. Read More
Eastman Kodak has landed a $765 million government loan to manufacture drug starting materials and active pharmaceutical ingredients in the U.S. Read More